Lilly’s Mounjaro (tirzepatide) demonstrated cardiovascular protection in a head-to-head trial
Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8 per cent lower rate of MACE-3 events, while…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Trulicity
Eli Lilly to invest $450 million more to expand capacity as obesity drug decision looms
The company has been struggling to meet strong demand for its incretin products, which include its diabetes drug Trulicity and…
Eli Lilly and Cipla enter into strategic partnership in India to enhance access to Lilly’s key…
As part of this agreement, Lilly will transfer its rights in India to sell, promote and distribute the aforesaid two Lilly…
Global diabetes therapeutic market has grown sixfold in last two decades: GlobalData
The market has been a lucrative space for drug developers, as the disease is highly prevalent and patient numbers are expected to…
Lilly gets US FDA nod for additional doses of Trulicity (dulaglutide) to treat type 2 diabetes
The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11 trial